Privia Health Group, Inc.

Privia Health Group, Inc. has achieved a new 52-week high, reflecting its strong performance in the insurance industry with a notable increase over the past year. The company, classified as small-cap, has a market capitalization of USD 2,476 million and unique financial metrics, including a high P/E ratio.

Privia Health Group, Inc. has achieved a new 52-week high, reflecting its strong performance in the insurance sector with a notable increase over the past year. The company, classified as small-cap, has a high P/E ratio and focuses on growth, with no dividend currently offered.

Privia Health Group, Inc. has shown notable stock performance, with significant gains over the past week and year-to-date. The company reported strong fundamentals, including substantial growth in net sales and operating profit, alongside a healthy operating cash flow and low debt-to-equity ratio, reinforcing its position in the insurance industry.

Privia Health Group, Inc. has recently experienced a change in its valuation grade, indicating a shift in market perception. Key financial metrics include a high P/E ratio of 181 and significant operating cash flow of USD 91.86 million, reflecting the company's evolving position in the insurance sector.

Privia Health Group, Inc. has experienced a valuation adjustment, reflected in its high P/E ratio of 181 and elevated price-to-book value of 4.29. Despite a year-to-date return of 19.85%, the company has underperformed the S&P 500 over the past three years, highlighting competitive challenges in the insurance sector.

Privia Health Group, Inc. achieved a new 52-week high of USD 26.51 on November 6, 2025, reflecting a 41.47% increase over the past year. With a market cap of USD 2,895 million, the company shows strong performance metrics, including a P/E ratio of 181.00 and a return on equity of 2.17%.

Privia Health Group, Inc. has recently adjusted its valuation, showcasing a notably high P/E ratio of 181 compared to industry peers. Its financial metrics, including a price-to-book value of 4.29 and an EV to EBITDA ratio of 82.17, highlight significant differences within the insurance sector.

Privia Health Group, Inc. has recently adjusted its valuation, showcasing a high P/E ratio of 181 compared to peers like Globe Life and Primerica. Despite a year-to-date return of 32.94%, Privia's three-year performance has declined by 19.34%, indicating contrasting trends within the insurance sector.

Privia Health Group, Inc. has experienced a valuation adjustment, reflected in its high P/E ratio of 181 and elevated price-to-book value of 4.29. Despite strong recent returns, its three-year performance has declined significantly compared to the S&P 500, indicating a contrasting market position within the insurance sector.

Privia Health Group, Inc. has recently achieved a Golden Cross, signaling a potential shift in momentum. Positive technical indicators, including bullish MACD trends and favorable Bollinger Bands, suggest a strong market position. Despite a decline over three years, the stock has significantly outperformed the S&P 500 in the past year and year-to-date.

Privia Health Group, Inc. has recently adjusted its valuation, with its stock price at $23.96. Over the past year, the company has achieved a 33.26% return, outperforming the S&P 500. Key metrics include a P/E ratio of 181 and a return on capital employed of 11.11%, indicating a unique market position.

Privia Health Group, Inc. has experienced a technical trend adjustment, with its stock price at $22.90. Over the past year, it has achieved a return of 22.13%, outperforming the S&P 500. The company shows mixed technical indicators, reflecting volatility and resilience in a competitive market.